Intimate protections, designed to absorb menstrual flow during menstruation, are classified into two categories: internal intimate protections (tampon, menstrual cup) and external intimate protections (disposable or washable sanitary pads, panty liner, menstrual panty). Recently, women's expectations have changed with a demand for transparency regarding intimate protection's composition and potential health risks. The choice and use of a type of intimate protection will depend on multiple factors specific to each woman. The cost of intimate protectioncould influence patient choice, as disposable sanitary pads are often less expensive.
- Study Type: Observational
- Study Design
- Time Perspective: Cross-Sectional
- Study Primary Completion Date: July 1, 2021
The primary objective is to describe medical students 's intimate protection practices.
- Other: Questionnaire regarding intimate protections habit.
- Questionnaire regarding intimate protections habit.
Arms, Groups and Cohorts
- Medical student
- Medical student aged more than 18, presenting menstrual cycles, and agreeing to participate in the study.
Clinical Trial Outcome Measures
- Use of internal intimate protections
- Time Frame: Day 0
- Number of patients using tampon or menstrual cup as hygienic protection
- Use of external intimate protections
- Time Frame: Day 0
- Number of patients using disposable sanitary pads, washable sanitary pads, panty liner or menstrual panty as hygienic protection
Participating in This Clinical Trial
- Female – Medical student – Aged more than 18 – Presenting menstrual cycles – Agreeing to participate in the study Exclusion Criteria:
- Aged less than 18
Gender Eligibility: Female
Minimum Age: 18 Years
Maximum Age: 50 Years
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
- Lead Sponsor
- Université de Reims Champagne-Ardenne
- Provider of Information About this Clinical Study
- Overall Official(s)
- Emilie RAIMOND, Principal Investigator, Université de Reims CHampahne-Ardenne – CHU de Reims
- Overall Contact(s)
- Emilie RAIMOND, 0664340843, firstname.lastname@example.org
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.